Copyright by Michael Jones, Bill Elkus, Jim Lyles, and Lisa Lewis 1995, 1996 - All rights reserved worldwide.
Disclaimer

Osteoporosis and Osteomalacia
in Patients with Celiac Disease

Elizabeth Shane, M.D., Endocrinologist

Metabolic Bone Disease Program
Columbia-Presbyterian Medical Center, New York City


Table of Contents

This is a presentation to the Greater NY Celiac Support Group, Columbia-Presbyterian Medical Center, October 9, 1996, summarized by Sue Goldstein

| Return to the Basic Information page. | Return to the FAQ. | | Return to the Celiac WWW page. |

Feedback to the Listowners.


AN OVERVIEW

Osteoporosis, the most common bone disease, is a disorder in which there is too little bone. Osteoporatic bone is normally mineralized, which means that for the volume of bone, it contains the correct amount of calcium and phosphorus, but there is too little of it. Because there is too little bone, the bone is not as strong as it should be, which increases the risk of fractures. Osteoporosis is an asymptomatic disease until there is a fracture; that may be the first time the diagnosis is entertained.

Normal bone is similar in appearance to a sea sponge. It is composed of thick interconnected plates separated by spaces. In osteoporosis, the plates gradually become thinner, then perforate and eventually disappear. Due to this deterioration in the architecture of bone, it becomes less able to withstand the stresses and strains of everyday life. A person may have osteoporosis and never have a broken bone. However, if they have a fall or other injury, they are more likely to break a bone than someone with normal bone.

In this country, approximately 1.5 million fractures occur every year. These include fractures of the vertebrae, the wrist, and the most dangerous and expensive of all - the hip fracture. As a consequence of hip fractures, more than 60,000 patients a year enter nursing homes. There are also many deaths during the first year after a hip fracture. It is much easier to prevent osteoporosis than to treat it once it has developed. Therefore, it is important to make the diagnosis as early as possible.

Return to the Table of Contents

RISK FACTORS

There are a number of factors that are associated with an increased risk of developing osteoporosis. These can be separated into two general categories: those you can change and those that you cannot change.

The factors that cannot be changed include:

    1. GENDER: Women have much lower bone density than men, and are at a higher risk for osteoporosis. Therefore, we need to be more vigilant about screening women for osteoporosis.

    2. RACE: Caucasians and people of Asian origin are at greater risk than people who are of African-American origin.

    3. GENETICS: To a major extent, bone density is genetically determined; a family history of fracture (particularly hip fracture) is an important risk factor.

    4. STATURE: People who are of short stature tend to have smaller, thinner bones.

    5. AGE: The incidence of new fractures increases dramatically with age in both men and women.

Risk factors that can be changed:

    1. DIET: A low calcium diet for many years has been shown to be associated with lower bone density. It is very important to maintain an adequate amount of calcium in the diet.

    2. ESTROGEN LEVELS: After menopause, there is a period of rapid bone loss because of estrogen deficiency. Women may also lose bone before menopause if they have infrequent menstrual periods or lack the normal amount of estrogen. Women can be treated with estrogen replacement therapy, if appropriate for them, at the time of menopause.

    3. EXERCISE: Weight-bearing exercise, such as walking or running, is the most effective in maintaining bone density. Walking 3 or 4 times a week for 30 minutes can do a lot to keep your bones healthy.

    4. HEALTHY LIFESTYLE CHOICES: Smoking prevents the deposition of new bone, and is associated with lower bone density in men and women. Two or more alcoholic drinks a day has been shown to have the same effect on bone as smoking. If you smoke and drink, the effects are additive.

    5. DRUGS: Many drugs in common use may affect bone density, such as glucocorticoids, thyroid hormone, heparin, and certain diuretics.

    6. DISEASES: Many diseases are associated with osteoporosis. It has become very clear that patients with Celiac Disease are at risk for osteoporosis.

Return to the Table of Contents

OSTEOPOROSIS AND OSTEOMALACIA ASSOCIATED WITH CELIAC DISEASE

It is likely that calcium malabsorption is the major factor causing osteoporosis in patients with Celiac Disease. Although it may be asymptomatic, Celiac Disease is a lifelong disease. If there is lifelong impairment in calcium absorption, bone density will be compromised. In addition, some patients with Celiac Disease may not have adequate vitamin D. Vitamin D is a hormone that fosters both absorption of calcium from the gut and deposition of calcium and phosphorus into bone. Both calcium and vitamin D are absorbed in the upper small intestine, which is the area of the intestine most frequently affected by Celiac Disease. Vitamin D can also be made in the skin from sun exposure. People who get adequate sunshine don’t really need vitamin D in their diet, and it doesn’t matter if they malabsorb vitamin D.

By the time a person reaches their twenties, they have probably achieved their peak bone mass, which is a major determinant of osteoporosis later in life. In general, people who have high peak bone mass at maturity will end up with the most bone and fewer fractures later in life. Once the forties are reached, bone mass begins to decrease gradually by 1-2% per year. Women also go through a period of more rapid bone loss during the 5 to 10 years after menopause. Calcium deficiency impacts on bone density early in life because you will make less bone, and later in life when you will lose more bone than an individual with enough calcium available.

The incidence of osteoporosis in patients with Celiac Disease varies somewhat. The incidence is higher with more severe disease and older age at diagnosis. When children present with Celiac Disease, they usually have evidence of delayed or poor growth, and bone density, if measured, is low. When a gluten-free diet is maintained, there is usually an increase in bone mass, and the growth rate usually improves. Some studies suggest that children with Celiac Disease who are diagnosed at a young age and treated effectively will have normal bone mass when they reach adulthood.

Adults who have had lifelong undiagnosed Celiac Disease are more likely to have lower bone density than the average person their age. They are significantly more likely to already have had broken bones than are age and sex matched controls.

Patients with Celiac Disease may also have a different bone disorder called osteomalacia. Osteomalacia differs in several respects from osteoporosis. In osteomalacia, the amount of bone may be normal, but there is less mineral in the bone. Bone formation is a two-step process. Bone is first made as soft tissue; after the bone has been laid down, calcium and phosphorus are deposited in the tissue, and it hardens. In osteomalacia, less calcium and phosphorus are deposited into bone. This makes the bone soft and more pliable. In children, the long bones of the legs will bend and bow, which is called rickets. In contrast to osteoporosis, there are usually symptoms with osteomalacia. The bones may ache and feel sore to the touch. For example, it is common to have hip or heel pain when you stand. Fractures do occur, but they tend to be a little different from osteoporatic fractures. It is important for the physician and the patient to know whether they’re dealing with osteoporosis or osteomalacia, because they are treated differently, and certain therapies that might make osteoporosis better might make osteomalacia worse. The definitive diagnosis of osteomalacia is made by bone biopsy, where excess unmineralized bone can be seen, although tests of blood and urine may also be helpful.

Return to the Table of Contents

DIAGNOSIS - BONE DENSITOMETRY AND OTHER TESTS

Bone densitometry is the best method we have available today for diagnosing low bone density. It is particularly useful for diagnosing osteoporosis before fractures occur. The best way to measure bone density is by Dual Energy X-ray Absorptiometry (DEXA).

A plain x-ray will not detect bone loss until 30% of the bone is gone; bone densitometry will detect bone loss much earlier. Bone densitometry is also easy and fast; depending on the manufacturer or age of the scanner, it will take anywhere from five to thirty minutes. Another strength of bone densitometry is its accuracy; if you do sequential bone densities, you can detect relatively small changes with a fair degree of certainty. Bone densitometry also has very low radiation exposure. The two most common types of bone density machines in use today are made by Hologic or Lunar. It is very important to try and be measured on the same machine, since measurements made on different machines do not always correlate well.

Patients with Celiac Disease should be evaluated for osteoporosis. Bone densitometry will tell you whether you have osteoporosis or not, and how you compare to other people your age. Certain blood tests are also essential. The concentration of calcium in the blood should be measured, because it is frankly low in many Celiac Disease patients. Phosphorus may also be low, and this blood test is helpful to the physician in evaluating the degree of involvement of your bones when you have Celiac Disease. The 25-hydroxyvitamin D blood level, which reflects the body’s stores of vitamin D should also be measured. Parathyroid hormone blood levels should also be measured; this test helps the physician know if the Celiac Disease is well controlled, whether there is a lot of bone loss going on, and whether the patient is getting adequate calcium or not.

It is also helpful to have a urinary calcium test, which involves a 24-hour urine collection, which helps in determining whether the patient is getting adequate calcium. Bone turnover markers are more specialized tests that assess whether there is a lot of bone loss going on. It has been shown that patients with Celiac Disease do have higher levels of bone turnover markers.

Return to the Table of Contents

TREATMENT FOR CELIAC PATIENTS WITH LOW BONE DENSITY

The most important treatment is the gluten-free diet. The available evidence suggests that if children or adults adhere to a gluten-free diet, bone density will improve, especially during the first year or two of treatment. If you’re an adult at age 30, who has just discovered that you have Celiac Disease and low bone density, your bone density may increase anywhere between 5-10% over the first year or two on a gluten-free diet. There are no good studies looking beyond 1-2 years.

Calcium supplements are important, and may be necessary even in those patients who have a good response to the gluten-free diet. Celiac Disease patients lose more calcium in bowel movements than normal people do, and there is a certain amount of calcium that is lost in the urine whether you have Celiac Disease or not. Calcium is necessary for a myriad of body processes, and if it doesn’t come from the diet or supplements, it is taken from the bones.

If the vitamin D level is low, supplements can be taken. Sometimes plain vitamin D doesn’t work, because it is not well absorbed. Other types of vitamin D can be prescribed by your physician that are more easily absorbed. Making sure you get a reasonable amount of sunlight exposure is also a good way to get more vitamin D.

Women with Celiac Disease who go through menopause should strongly consider taking estrogen, which will protect them from the additional bone loss that occurs with estrogen deficiency.

There are other newer therapies for osteoporosis. None of them have been evaluated in patients with Celiac Disease. The new Merck drug, Fosamax (Alendronate), is absorbed mainly in the stomach, and should be absorbed in the patient with Celiac Disease. It does not contain gluten, but does contain lactose. The decision to institute Fosamax therapy is a very individual one that should be reached between the Celiac Disease patient and their doctor after a careful evaluation to make sure that there is no evidence of osteomalacia. Fosamax may make osteomalacia worse. Moreover, at this time we don’t really know if Fosamax is effective. The other agent that is approved for osteoporosis is calcitonin, which is available in a nasal spray. Calcitonin probably won’t hurt anybody, but there is no information available about whether it helps. Newer agents that act by different mechanisms to increase bone density are now in clinical trials.

Return to the Table of Contents

SELECTED QUESTIONS AND ANSWERS

Q: What is the diagnostic test for osteomalacia and what is the treatment?

A: The diagnosis is helped by the blood tests that we discussed, but the only way to make a firm diagnosis is with a biopsy of the bone. Osteomalacia is treated with a lot of vitamin D and calcium. If the patient cannot absorb vitamin D, a way to get enough vitamin D has to be found. Since vitamin D is made in the skin, you can make enough vitamin D from sitting out in the sun 15-20 minutes a day. In northern latitudes like ours, there is not enough sunlight during the winter months to form sufficient vitamin D. Therefore, it is wise to get a little extra sunlight in the summer.

Q: Is weight-training beneficial for increasing bone density?

A: Exercise studies are very difficult to do and evaluate. The best data has shown walking to be the best exercise for increasing bone density. Weight-training can increase strength, flexibility and muscle tone, and impedes aging, so it is encouraged, although it hasn’t been proven to directly increase bone density.

Q: Would a CAT scan be a good test to measure bone density?

A: I do not recommend CAT scans, which have very high radiation. Moreover, the hip is not usually measured, which is very important, particularly in older people. Also, it is not as reproducible as DEXA when yearly tests are ordered to see if you are responding to therapy.

Q: How much calcium should be taken in one dose?

A: The most efficient absorption of calcium is from a 500 mg. dose. Taking supplements in 500 mg. doses during the day is best. Calcium carbonate should be taken with food for best absorption. Calcium citrate does not need to be taken with food.

Q: What are the recommended daily allowances of calcium?

A: Men and premenopausal women and postmenopausal women taking estrogen need a total of 1000 mg. of calcium a day from dietary sources or supplements. Postmenopausal women who are not on estrogen need 1500 mg. of calcium a day. Before age 10, children need 800 mg. a day. Adolescents, from age 10 and up, require 1500 mg. a day. Celiac patients may need more than the recommended allowances; this would need to be determined on an individual basis.

Q: Are magnesium and zinc supplements beneficial for bone? What about boron?

A: Magnesium would be helpful only if the patient has magnesium deficiency; otherwise there is no evidence that it improves the absorption of calcium or the effect of calcium on bone. I’m not aware of any evidence of zinc or boron having any benefits.

| Return to the Table of Contents. | Return to the Basic Information page. | Return to the FAQ. |
| Return to the Celiac WWW page. |

Copyright

Permission is granted to copy this document, at no charge and in its entirety, provided that the copies are not used for commercial advantage, that the source is cited and that the present copyright notice is included in all copies, so that the recipients of such copies are equally bound to abide by the present conditions. Prior written permission is required for any commercial use of this document, in whole or in part, and for any partial reproduction of the contents of this document exceeding 50 lines of up to 80 characters, or equivalent. The title page, table of contents and index, if any, are not considered to be part of the document for the purposes of this copyright notice, and can be freely removed if present.

The purpose of this copyright is to protect your right to make free copies of this paper for your friends and colleagues, to prevent publishers from using it for commercial advantage, and to prevent ill-meaning people from altering the meaning of the document by changing or removing a few paragraphs.

Return to the Table of Contents

Disclaimer

This fact sheet has been designed to be a general information resource. However, it is not intended for use in diagnosis, treatment, or any other medical application. Questions should be directed to your personal physician. This information is not warranted and no liability is assumed by the author or any group for the recommendations, information, dietary suggestions, menus, and recipes promulgated. Based upon accepted practices in supplying the source documents, this fact sheet is accurate and complete. Products mentioned or omitted do not constitute endorsement.

Return to the Table of Contents